Geode Capital Management
FATE icon

Geode Capital Management’s Fate Therapeutics FATE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.72M Buy
2,429,167
+159,558
+7% +$179K ﹤0.01% 3034
2025
Q1
$1.79M Buy
2,269,609
+42,642
+2% +$33.7K ﹤0.01% 3081
2024
Q4
$3.68M Sell
2,226,967
-31,279
-1% -$51.6K ﹤0.01% 2892
2024
Q3
$7.91M Buy
2,258,246
+10,863
+0.5% +$38K ﹤0.01% 2507
2024
Q2
$7.37M Buy
2,247,383
+341,400
+18% +$1.12M ﹤0.01% 2508
2024
Q1
$14M Buy
1,905,983
+42,498
+2% +$312K ﹤0.01% 2125
2023
Q4
$6.97M Buy
1,863,485
+88,141
+5% +$330K ﹤0.01% 2531
2023
Q3
$3.76M Buy
1,775,344
+30,232
+2% +$64.1K ﹤0.01% 2785
2023
Q2
$8.31M Buy
1,745,112
+132,523
+8% +$631K ﹤0.01% 2397
2023
Q1
$9.19M Buy
1,612,589
+48,298
+3% +$275K ﹤0.01% 2303
2022
Q4
$15.8M Buy
1,564,291
+64,611
+4% +$652K ﹤0.01% 1933
2022
Q3
$33.6M Buy
1,499,680
+34,002
+2% +$762K 0.01% 1373
2022
Q2
$36.3M Sell
1,465,678
-8,549
-0.6% -$212K 0.01% 1335
2022
Q1
$57.2M Buy
1,474,227
+48,259
+3% +$1.87M 0.01% 1152
2021
Q4
$83.4M Buy
1,425,968
+21,872
+2% +$1.28M 0.01% 933
2021
Q3
$83.2M Sell
1,404,096
-14,310
-1% -$848K 0.01% 918
2021
Q2
$123M Buy
1,418,406
+69,094
+5% +$6M 0.02% 697
2021
Q1
$111M Buy
1,349,312
+189,798
+16% +$15.6M 0.02% 704
2020
Q4
$105M Buy
1,159,514
+56,024
+5% +$5.09M 0.02% 667
2020
Q3
$44.1M Buy
1,103,490
+72,164
+7% +$2.88M 0.01% 988
2020
Q2
$35.4M Buy
1,031,326
+82,538
+9% +$2.83M 0.01% 1094
2020
Q1
$21.1M Buy
948,788
+71,953
+8% +$1.6M 0.01% 1256
2019
Q4
$17.2M Buy
876,835
+64,302
+8% +$1.26M ﹤0.01% 1661
2019
Q3
$12.6M Buy
812,533
+9,580
+1% +$149K ﹤0.01% 1776
2019
Q2
$16.3M Buy
802,953
+12,082
+2% +$245K ﹤0.01% 1621
2019
Q1
$13.9M Buy
790,871
+88,692
+13% +$1.56M ﹤0.01% 1677
2018
Q4
$9.01M Buy
702,179
+186,927
+36% +$2.4M ﹤0.01% 1846
2018
Q3
$8.39M Buy
515,252
+62,326
+14% +$1.02M ﹤0.01% 2046
2018
Q2
$5.14M Buy
452,926
+48,292
+12% +$548K ﹤0.01% 2306
2018
Q1
$3.95M Buy
404,634
+57,061
+16% +$557K ﹤0.01% 2390
2017
Q4
$2.12M Buy
347,573
+45,142
+15% +$276K ﹤0.01% 2715
2017
Q3
$1.2M Buy
302,431
+125,349
+71% +$496K ﹤0.01% 3038
2017
Q2
$573K Buy
177,082
+57,568
+48% +$186K ﹤0.01% 3312
2017
Q1
$543K Buy
119,514
+4,098
+4% +$18.6K ﹤0.01% 3278
2016
Q4
$289K Buy
115,416
+7,323
+7% +$18.3K ﹤0.01% 3467
2016
Q3
$337K Buy
108,093
+64
+0.1% +$200 ﹤0.01% 3411
2016
Q2
$183K Hold
108,029
﹤0.01% 3620
2016
Q1
$194 Sell
108,029
-64
-0.1% ﹤0.01% 3646
2015
Q4
$364K Buy
108,093
+128
+0.1% +$431 ﹤0.01% 3415
2015
Q3
$575K Buy
107,965
+30,018
+39% +$160K ﹤0.01% 3164
2015
Q2
$504K Buy
77,947
+46,371
+147% +$300K ﹤0.01% 3190
2015
Q1
$154K Buy
31,576
+192
+0.6% +$936 ﹤0.01% 3661
2014
Q4
$157K Buy
31,384
+192
+0.6% +$960 ﹤0.01% 3672
2014
Q3
$160K Buy
31,192
+7,528
+32% +$38.6K ﹤0.01% 3645
2014
Q2
$149K Sell
23,664
-64
-0.3% -$403 ﹤0.01% 3602
2014
Q1
$231K Buy
+23,728
New +$231K ﹤0.01% 3454